Opioid equivalence shouldn't be useful for opioid conversion. To do so is an inappropriate and perhaps dangerous misunderstanding of your tool.Below the requirements of the REMS, drug corporations with authorized opioid analgesic products ought to make REMS-compliant education programs available to Health care providers. Healthcare providers are st